About 100,000 people in the U.S. have sickle cell disease, a condition that primarily affects people of color, the CDC says.

Genetics is rarely as straightforward as a single gene driving a lone health outcome. But a new study has uncovered what could be a rare exception. Changes to just one gene, called GRIN2A, have now ...

Encoded Therapeutics has linked its Dravet syndrome gene therapy ETX101 to a 78% reduction in seizures, keeping the biotech ...

The European Union has reached a preliminary deal on how to regulate gene-edited crops in a move that could ease the development of new varieties in a region long wary of biotech innovations in food.

Kian Sadeghi, the 25-year-old founder and CEO at Nucleus Genomics, tells "CBS Mornings" that parents have every right to select the qualities and traits they desire in their child.

Regeneron is adding its name to Tessera Therapeutics’ unique in vivo gene writing program, inking a deal that lets it in on a ...